Home » Topics » Disease categories and therapies » Gastrointestinal

Gastrointestinal
RSS

Novel IL-33-dependent mouse model of eosinophilic esophagitis

March 3, 2022

New SLC10A2/SLC10A1 inhibitors identified at Albireo

March 3, 2022

LIGHT mediates esophageal remodeling in murine model of eosinophilic esophagitis

March 2, 2022

IL13RA1 is a therapeutic target in the treatment of EoE

March 1, 2022

NovoBiome and Inserm collaborate on intestinal organoid-on-a-chip technology

Feb. 22, 2022

IBD-3540, a novel gut-restricted GCPII inhibitor with oral preclinical activity in models of colitis

Feb. 21, 2022

Lipidated IL-22 ameliorates colon inflammation in preclinical colitis model

Feb. 21, 2022

Targeting PFKFB3 reduces the severity of colitis in mouse models

Feb. 18, 2022

Targeting GDNF may have potential to treat IBD

Feb. 18, 2022

Nrf2 agonists ameliorate anemia of inflammation by disrupting the hepcidin-ferroportin axis

Feb. 18, 2022

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 6, 2026.
CROI 2026 highlights depression and cognitive vulnerability in HIV
BioWorld
The effects of aging pose an additional challenge for people with HIV due to the neurological and psychological consequences that persist despite antiretroviral...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
University of Southern California reports new MAPT aggregation inhibitors
BioWorld Science
The University of Southern California has identified (2-oxo-2H-chromen-3-yl) scaffold-based carboxamide analogues acting as potent microtubule-associated protein...
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...